Rights and permissions
About this article
Cite this article
ADR-related costs higher with amoxicillin/clavulanic acid. Pharmacoecon. Outcomes News 495, 5 (2006). https://doi.org/10.2165/00151234-200604950-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200604950-00011